SEARCH

SEARCH BY CITATION

References

  • AKERMAN, S., WILLIAMSON, D., KAUBE, H., HILL, R.G. & GOADSBY, P.J. (2001). The effect of nitric oxide and nitric oxide synthase inhibitors on rat dural meningeal vessels. Cephalalgia, 21, 276277.
  • ASHINA, M., LASSEN, L.H., BENDTSEN, L., JENSEN, R. & OLESEN, J. (1999). Effect of inhibition of nitric oxide synthase on chronic tension-type headache. Lancet, 353, 287289.
  • EDVINSSON, L. (1999). Experimental Headache Models in Animals and Man, London: Martin Dunitz.
  • EDVINSSON, L., EKMAN, R., JANSEN, I., MCCULLOCH, J. & UDDMAN, R. (1987). Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J. Cereb. Blood Flow Metabol., 7, 720728.
  • EDVINSSON, L., MULDER, H., GOADSBY, P.J. & UDDMAN, R. (1998). Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J. Auto. Nerv. Syst., 70, 1522.
  • FERRARI, M.D., ROON, K.I., LIPTON, R.B. & GOADSBY, P.J. (2001). Triptans (Serotonin, 5-HT1B/1D agonists) in acute migraine treatment – a meta-analysis of 53 trials. Lancet, 358, 16681675.
  • GALLAI, V., SARCHIELLI, P., FLORIDI, A., FRANCESCHINI, M., CODINI, M., TREQUATTRINI, A. & PALUMBO, R. (1995). Vasoactive peptides levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia, 15, 384390.
  • GOADSBY, P.J. (2000). The pharmacology of headache. Prog. Neurobiol., 62, 509525.
  • GOADSBY, P.J. (2001). The pathophysiology of headache. In Wolff's Headache and Other Head Pain. ed. Silberstein, S.D., Lipton, R.B. & Solomon, S. pp. 5772, Oxford: Oxford University Press.
  • GOADSBY, P.J. & EDVINSSON, L. (1993). The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol., 33, 4856.
  • GOADSBY, P.J., EDVINSSON, L. & EKMAN, R. (1990). Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol., 28, 183187.
  • GRAY, D.W. & MARSHALL, I. (1992a). Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br. J. Pharmacol., 107, 691696.
  • GRAY, D.W. & MARSHALL, I. (1992b). Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta. Eur. J. Pharmacol., 212, 3742.
  • HEADACHE CLASSIFICATION COMMITTEE OF THE INTERNATIONAL HEADACHE SOCIETY (1988). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia, 8, 196.
  • HOSKIN, K.L., BULMER, D.C.E. & GOADSBY, P.J. (1999). Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. Neurosci. Lett., 266, 173176.
  • IVERSEN, H.K., OLESEN, J. & TFELT-HANSEN, P. (1989). Intravenous nitroglycerin as an experimental headache model. Basic characteristics. Pain, 38, 1724.
  • JANSEN, I., ALAFACI, C., MCCULLOCH, J., UDDMAN, R. & EDVINSSON, L. (1991). Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: vasomotor responses in vitro and in situ. J. Cereb. Blood Flow Metab., 11, 567575.
  • JANSEN OLESEN, I., OTTOSSON, A., CANTERA, L., STRUNK, S., LASSEN, L.H., OLESEN, J., MORTENSEN, A., ENGEL, U. & EDVINSSON, L. (1997). Role of endothelium and nitric oxide in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1- and H2-receptors by RT–PCR. Br. J. Pharmacol., 121, 4148.
  • JONES, M.G., LEVER, I., BINGHAM, S., READ, S., MCMAHON, S.B. & PARSONS, A. (2001). Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat. Cephalalgia, 21, 643655.
  • KNIGHT, Y.E. & GOADSBY, P.J. (2001). The periaqueductal gray matter modulates trigeminovascular input: a role in migraine? Neuroscience, 106, 793800.
  • KRABBE, A.E. & OLESEN, J. (1980). Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms. Pain, 8, 253259.
  • LAMBERT, G.A., DONALDSON, C., BOERS, P.M. & ZAGAMI, A.S. (2000). Activation of trigeminovascular neurons by glycerol trinitrate. Brain Res., 887, 253259.
  • LASSEN, L.H., ASHINA, M., CHRISTIANSEN, I., ULRICH, V. & OLESEN, J. (1997). Nitric oxide synthesis inhibition in migraine. Lancet, 349, 401402.
  • LASSEN, L.H., THOMSEN, L.L. & OLESEN, J. (1995). Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine. Neuroreport, 6, 14751479.
  • MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109142.
  • OLESEN, J., IVERSEN, H.K. & THOMSEN, L.L. (1993). Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport, 4, 10271030.
  • OLESEN, J., THOMSEN, L.L. & IVERSEN, H.K. (1994). Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol. Sci., 15, 149153.
  • OLESEN, J., THOMSEN, L.L., LASSEN, L.H. & OLESEN, I.J. (1995). The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia, 15, 94100.
  • TASSORELLI, C., COSTA, A., BLANDINI, F., JOSEPH, S.A. & NAPPI, G. (2000). Effect of nitric oxide donors on the central nervous system – Nitroglycerin studies in the rat. Functional Neurol., 15, 1927.
  • TASSORELLI, C. & JOSEPH, S.A. (1995). Systemic nitroglycerin induces Fos immunoreactivity in brain-stem and forebrain structures of the rat. Brain Res., 682, 167181.
  • TASSORELLI, C., JOSEPH, S.A. & NAPPI, G. (1997). Neurochemical mechanisms of nitroglycerin-induced neuronal activation in rat brain: a pharmacological investigation. Neuropharmacology, 36, 14171424.
  • THOMSEN, L.L., KRUUSE, C., IVERSEN, H.K. & OLESEN, J. (1994). A nitric oxide donor (nitroglycerine) triggers genuine migraine attacks. Eur. J. Neurol., 1, 7380.
  • THOMSEN, L.L. & OLESEN, J. (1997). A pivotal role of nitric oxide in migraine pain. Ann. NY Acad. Sci., 835, 363372.
  • WAHL, M., SCHILLING, L., PARSONS, A.A. & KAUFMANN, A.J. (1994). Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res., 637, 204210.
  • WEI, E.P., MOSKOWITZ, M.A., BOCCALINI, P. & KONTOS, H.A. (1992). Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ. Res., 70, 13131319.
  • WILLIAMSON, D.J., HARGREAVES, R.J., HILL, R.G. & SHEPHEARD, S.L. (1997a). Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural blood vessel diameter in the anaesthetized rat. Cephalalgia, 17, 518524.
  • WILLIAMSON, D.J., HARGREAVES, R.J., HILL, R.G. & SHEPHEARD, S.L. (1997b). Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat-intravital microscope studies. Cephalalgia, 17, 525531.
  • WILLIAMSON, D.J., SHEPHEARD, S.L., HILL, R.G. & HARGREAVES, R.J. (1997c). The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilatation and extravasation. Eur. J. Pharmacol., 328, 6164.